Gardasil 9 Indications/Uses

GARDASIL 9 is a vaccine indicated in girls and women from 9 through 45 years of age for the prevention of cervical, vulvar, vaginal and anal cancer, precancerous or dysplastic lesions and genital warts caused by Human Papillomavirus (HPV).
GARDASIL 9 is indicated to prevent the following diseases: Cervical, vulvar, vaginal, and anal cancer caused by HPV types 16, 18, 31, 33, 45, 52, and 58.
Genital warts (condyloma acuminata) caused by HPV types 6 and 11.
And the following precancerous or dysplastic lesions caused by HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58: Cervical intraepithelial neoplasia (CIN) grade 2/3 and Cervical adenocarcinoma in situ (AIS).
Cervical intraepithelial neoplasia (CIN) grade 1.
Vulvar intraepithelial neoplasia (VIN) grade 2 and grade 3.
Vaginal intraepithelial neoplasia (VaIN) grade 2 and grade 3.
Anal intraepithelial neoplasia (AIN) grades 1, 2, and 3.
GARDASIL 9 is indicated in boys and men from 9 through 45 years of age for the prevention of anal cancer, anal precancerous or dysplastic lesions and external genital lesions (including genital warts) caused by HPV.
GARDASIL 9 is indicated to prevent the following diseases: Anal cancer caused by HPV types 16, 18, 31, 33, 45, 52, and 58.
Genital warts (condyloma acuminata) caused by HPV types 6 and 11.
And the following precancerous or dysplastic lesions caused by HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58: Anal intraepithelial neoplasia (AIN) grades 1, 2, and 3.